Moussa, Rayan S <br/><br/>
Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity.  [electronic resource] 

 -  Free radical biology & medicine  03 2019 
 - 276-294 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1873-4596 
<br/><br/><label>Standard No.: </label>10.1016/j.freeradbiomed.2018.03.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Binding Sites--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--antagonists & inhibitors<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Iron--metabolism<br/>Iron Chelating Agents--therapeutic use<br/>Neoplasms--drug therapy<br/>Sp1 Transcription Factor--genetics